The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
EMED · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
VXRT · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | EMED | ABBV | VXRT | MTEX |
|---|---|---|---|---|
| Moat Score (0–100) | 59 (highest) | 59 (highest) | 59 (highest) | 58 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 63 | 39 | 85 (highest) | 15 |
| Pricing power | 99 | 95 | — | 100 (highest) |
| Returns on capital | — | 97 (highest) | 6 | 84 |
| Balance-sheet safety | 28 | 26 | 100 (highest) | 28 |
| Capital allocation | 44 | 38 | 44 | 64 (highest) |
| No price data | 223% above value if growth stopped today | No price data | No price data | |
| Market cap | $46329 | $458.5B | $120M | $8.6M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2023 | FY2025 | FY2025 | FY2025 |